Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus

No commercial vaccine is yet available against Group A Streptococcus (GAS), major cause of pharyngitis and impetigo, with a high frequency of serious sequelae in low- and middle-income countries. Group A Carbohydrate (GAC), conjugated to an appropriate carrier protein, has been proposed as an attrac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Di Benedetto, Roberta, Mancini, Francesca, Carducci, Martina, Gasperini, Gianmarco, Moriel, Danilo Gomes, Saul, Allan, Necchi, Francesca, Rappuoli, Rino, Micoli, Francesca
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7696035/
https://ncbi.nlm.nih.gov/pubmed/33202815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21228558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados